CCSB will continuously pursuit the goal of
quality product,
quality service and quality people to become
a world-wide major supplier
of high quality APIs with competitive
prices.
Chunghwa Chemical Synthesis & Biotech Co.
Ltd. (CCSB) founded in 1964, is the largest
bulk pharmaceutical manufacturer in Taiwan,
located in the suburb of Taipei
with a
manufacturing
site of 8.7 acres.
CCSB
is a member company of CHINA CHEMICAL
PHARMACEUTICAL GROUP (CCPG).
its affiliates, China
Chemical Pharmaceutical Corporation (CCPC)
in Taiwan and Suzhou
Chung-Hwa Chemical and
Pharmaceutical Industrial Co. Ltd. (SCCPC)
in Suzhou, China
constitute two of the largest
pharmaceutical formulators in these areas.
The most recent investment to
construct and upgrade these three companies
amounts to $100
millions US dollars.
CCSB
has developed more than 30 bulk
pharmaceutical products including
Anti-Anxiety agent;
Antidiabetics; Laxatives; Antifungals;
Antihistamines; Antiseptics; Antiulcerants;
Cardiovascular drugs; Skeletal and muscle
relaxants,
Hypolipaemics and immunosuppresant.
In
1984, CCSB was the first pharmaceutical
manufacturer in Taiwan inspected and
approved
by
FDA for cGMP compliance. CCSB has filed
DMF's for 13 products with the FDA.
In April 2002,CCSB passed again the FDA
inspection of their cGMP plant to produce
synthesis and
biotechnology products.
CCSB has
established a sales office, in 1999
PHARMAPORTS
LLC in Montvale, New Jersey,
USA to promote
its products and provide better services to
the North American region.
Together, the
group has formed an international network
providing pharmaceutical ingredients
and finished
dosages.
|
